MD as CEO: Pro or Con-Steven R. Deitcher, MD-10/11/2011 - 6:00pm

Event Information
Event Topic: 
MD as CEO: Pro or Con
Event Date: 
10/11/2011 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Speaker Information
Event Speaker: 
Steven R. Deitcher, MD
Event Speaker Title: 
President and Chief Executive Officer
Event Speaker Company: 
Talon Therapeutics
Event Speaker Bio: 

Steven R. Deitcher, MD, was appointed President and Chief Executive Officer and a member of the Board of Directors for Hana Biosciences, now Talon Therapeutics, in August 2007. Dr. Deitcher originally joined Talon (Hana) as Executive Vice President of Development and Chief Medical Officer in May 2007. Since joining the company, Dr. Deitcher has transformed the organization into a focused, expert, and well-capitalized oncology drug development company. He is responsible for the rapid advancement (acceleration and amplification) of the Marqibo and Menadione Programs in particular. Prior to joining Talon (Hana), Dr. Deitcher served as Vice President, Chief Medical Scientist at Nuvelo where he was responsible for clinical development and medical affairs. Dr. Deitcher has more than 20 years of experience as a academic physician in hematology, medical oncology and clinical thrombosis vascular medicine.
Dr. Deitcher was formerly the head of the section of hematology and coagulation medicine in the department of hematology/oncology and director of research in the department of vascular medicine at The Cleveland Clinic Foundation. While at The Cleveland Clinic, Dr. Deitcher was hematology medical director for the Network for Oncology Communication and Research. Prior to that, he spent four years at The University of Tennessee in positions including associate chairman, department of medicine; director, combined pediatric and adult thrombosis clinic; and director, special and molecular coagulation laboratory.
Dr. Deitcher earned his B.S. and M.D. in the Honors Program in Medical Education at Northwestern University Medical School. He completed his residency in internal medicine at Barnes Hospital and completed his fellowship training in hematology and medical oncology at New England Medical Center and Tufts University School of Medicine. Dr. Deitcher is a member of several medical societies, including The American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research, and is a fellow of the Society for Vascular Medicine and Biology. He has published more than 190 peer-reviewed journal papers, abstracts and book chapters.

Event Details
Cost: 
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

Dr. Deitcher, MD, will be speaking on subject of physician-biopharma CEO interface and how medical background helped and at time hindered him in a business environment.